Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO COVID-19 AND NEUROSCIENCES

April 2021

NEUROSCIENCES

HISTORY OF NEUROLOGICAL DISORDER INCREASES RISK OF HOSPITAL REENCOUNTER AFTER COVID-19

Featuring: Eric Liotta, MD, MS, and Ayush Batra, MD
​
A new Northwestern Medicine study published in GeroScience analyzed 509 patients hospitalized for COVID-19 and found that needing to return to the hospital after initial COVID-19 hospitalization is common and that recurrence of COVID-19 symptoms is the leading reason patients seek hospital-level care within 30 days of discharge. The study conducted by the Northwestern Medicine Neuro COVID-19 research group also discovered that patients with a history of neurologic disorders before COVID-19 were at elevated risk to return to the hospital. However, steroid treatment during the initial hospitalization may reduce COVID-19 symptom recurrence that necessitates a return for hospital-level care.

“We were surprised to find that a history of neurologic disorders was the only comorbidity that predicted an increased risk for recurrent medical complications that required hospital-level care, both at 30 days and four months,” says Eric Liotta, MD, a Northwestern Medicine neurocritical care specialist who treats COVID-19 patients at Northwestern Memorial Hospital and co-authored the study. “Neither age, need for mechanical ventilation during COVID-19, nor length of the COVID-19 hospitalization predicted having a hospital reencounter. This finding highlights the unique role of the nervous system in COVID-19 and COVID-19 recovery, a role which has been suggested by other major research groups.”

The 509 patients included in the study were first hospitalized for COVID-19 within the Northwestern Medicine health system between March 5 to April 6, 2020. Of the 509 patients:

• 466 patients (91.6%) were discharged alive from the hospital
-Within 30 days, 12.4% needed hospital-level care
-Within four months, 21.5% of patients needed hospital-level care

• Recurrence of COVID-19 symptoms – including shortness of breath, fatigue, fever and respiratory distress – was the leading reason for hospital-level care, with other leading reasons including:
-Bacterial pneumonia
-Other pulmonary complications
-Infections besides pneumonia
-Bleeding

• Older patients and those with diabetes, chronic obstructive pulmonary disease or organ transplantation had more frequent reencounters

• More than 40% of patients with reencounters had a history of neurological disorders before COVID-19, including epilepsy, stroke, dementia, migraines, spinal stenosis and peripheral neuropathy

The study also found that steroid therapy during the initial hospitalization reduced the need to return to the hospital within 30 days of discharge. Furthermore, patients who continued to test positive for COVID-19 on nasal swabs returned more frequently to the hospital over four months, which supports the idea of a post-viral syndrome in COVID-19.

“Needing to return to the hospital after having been hospitalized for COVID-19 is common,” says Ayush Batra, MD, a Northwestern Medicine neurocritical care specialist who treats COVID-19 patients at Northwestern Memorial Hospital and co-authored the study. “Our future work will seek to identify the full range of symptoms experienced by patients following hospitalization for COVID-19, the duration of those symptoms and their impact on function and quality of life. Additionally, we will assess if specific interventions, such as steroids during COVID-19 hospitalization, demonstrate evidence of mitigating symptoms and improving recovery from COVID-19.”

The Northwestern Medicine Neuro COVID-19 research group also published studies on the neurologic manifestations in patients hospitalized with COVID-19 and the impact on non-hospitalized COVID-19 long-haulers.

To learn more about Northwestern Medicine or the Neuro COVID-19 Clinic, visit nm.org.
Headshot of Eric Liotta, MD, MS
Eric Liotta, MD, MS, Assistant Professor of Neurology (Neurocritical Care) and Surgery (Organ Transplantation), and co-author of the study.
Headshot of Ayush Batra, MD
Ayush Batra, MD, Assistant Professor of Neurology (Neurocritical Care) and Pathology, and co-author of the study.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you on the care of your patients. 
Call 844.344.6663
Find an NM Neurologist
Find an NM Neurosurgeon
Find an NM Neuroradiologist

You May Also Like

RNA

April 2021

NEUROSCIENCES
Protein Variant May Have Potential as Target for Glioblastoma
RCC1-GFP fusion protein

February 2021

NEUROSCIENCES
Blocking Cell Division in Glioblastoma
Medical illustration of tumor cell

August 2020

NEUROSCIENCES
Analyzing Plasma Can Classify Brain Tumors

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties